ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA. J Popl Ther Clin Pharmacol [Internet]. 2024 Sep. 7 [cited 2024 Sep. 28];31(9):731-40. Available from: https://jptcp.com/index.php/jptcp/article/view/7835